Sort   by:  
 Page size 
UnknownAbdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing-A prevalence study of patients in Mecklenburg-West Pomerania (2017-2021).
Not available
S-EPMC10808308 | biostudies-literature
UnknownUltradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania.
Not available
S-EPMC7737343 | biostudies-literature
UnknownNovel Isoquinolinamine and Isoindoloquinazolinone Compounds Exhibit Antiproliferative Activity in Acute Lymphoblastic Leukemia Cells.
Not available
S-EPMC6720533 | biostudies-literature
UnknownMolecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse.
Not available
S-EPMC9316692 | biostudies-literature
UnknownPhosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells.
Not available
S-EPMC5500767 | biostudies-literature
UnknownCombined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.
Not available
S-EPMC7967241 | biostudies-literature
UnknownDecitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements.
Not available
S-EPMC5936021 | biostudies-literature
UnknownInfluence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
Not available
S-EPMC7057698 | biostudies-literature
UnknownCombined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Not available
S-EPMC6404304 | biostudies-literature
UnknownKMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.
Not available
S-EPMC12077275 | biostudies-literature
Sort   by:  
 Page size